icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

Canada Goes Fully Legal

By Yona Torres Editor New Frontier Data All eyes are on Canada as the country takes its first few steps into a fully legal cannabis landscape. As such, Canada is taking a measured pace in its rollout of legal adult-use cannabis. The country is currently limiting its product offerings and will not permit edibles. “We […]
Read more

Mile High Labs Funding Round Underscores Contrasts in Cannabis Wholesaling

By J.J. McCoy, Senior Managing Editor, New Frontier Data Mile High Labs caught attention last week with the company’s announcement of a $35 million raise in what was described as the “largest Series A financing in the cannabis market history.” It was a newsworthy claim for the Colorado cannabis extraction company, and demonstrated its commitment toward […]
Read more

New York State Holds ‘Listening Sessions’ on Cannabis Legalization

By Noah Potter, Of Counsel to Hoban Law Group Last month, New York State Governor Andrew Cuomo’s office announced a series of 15 listening sessions about cannabis legalization (including one in Manhattan last week) to hear public comment through October. Cuomo’s new approach contrasts with the process that resulted in enactment of the Compassionate Care […]
Read more

New ‘Cannabis Energy Report’ Examines Cultivation Efficiencies, Cost Savings

By J.J. McCoy, Senior Managing Editor, for New Frontier Data In the forthcoming Cannabis Energy Report, New Frontier Data has joined both Scale MicroGrid Solutions and the Resource Innovation Institute to provide a landmark, comprehensive study about energy usage and carbon emissions throughout the cultivation cycles of cannabis. The study examines North American cultivators’ and operators’ [...]
Read more
US hemp based sales

Passage of Legalization Puts California Out Front for Hemp

By William Sumner, Hemp Business Journal Contributor A victory for the legal hemp industry was struck late last month as California Governor Jerry Brown signed into law SB 1409, to legalize hemp farming in the state. Included in the law are a series of provisions to clarify and resolve various conflicts between state laws and […]
Read more

DEA’s Rescheduling of CBD Is No Industry Cure-All

By J.J. McCoy, Senior Managing Editor, for New Frontier Data Recent news that the U.S. Drug Enforcement Agency (DEA) is rescheduling cannabidiol (CBD) for use in FDA-approved medicine was warmly welcomed by the cannabis industry, but it felt confusingly tepid on delivery. Overall, the announcement is a boon for Big Pharma companies looking to develop and […]
Read more

Hemp Stocks: A Look at Leading Public Hemp Companies

By William Sumner, Hemp Business Journal Contributor Last week, the hemp industry was abuzz with the news that the United States Drug Enforcement Administration (DEA) would move Epidiolex, a CBD-based drug derived from cannabis, from a Schedule I substance to a Schedule V substance. The scheduling does not explicitly pertain to CBD, but it does […]
Read more

Capturing the Energy Costs for Cannabis Cultivation

Capturing the Energy Costs for Cannabis Cultivation By J.J. McCoy and Beau Whitney for New Frontier Data Cannabis industry stakeholders, much like other stakeholders operating in agricultural and livestock commodities, place a great deal of emphasis on energy consumption and carbon-emissions levels. Whether framed by cultivators and producers as economic fixed costs, ongoing governmental [...]
Read more

Awaiting Word on Rescheduling, the Market Watches Epidiolex

By William Sumner, Hemp Business Journal Contributor Pending word at any time, the United States Drug Enforcement Administration (DEA) is expected to reschedule Epidiolex, a CBD-based drug derived from cannabis. An announcement was due on Sept. 23, but by press time remained forthcoming. Manufactured by the London-based GW Pharmaceuticals, the drug has been shown to […]
Read more

Navigating the Maze of the Cannabis Market After the Daze of Summer

By J.J. McCoy, Senior Managing Editor, for New Frontier Data Even before word of the DEA’s landmark rescheduling of cannabidiol (CBD) for GW Pharmaceutical’s FDA-approved Epidiolex, the cannabis market has had a hot summer. Medical cannabis is now legal in 31 states and the District of Columbia, with adult-use markets open in 9 of them plus […]
Read more